Cite

HARVARD Citation

    Sakurai, R. et al. (2020). Clinical significance of topoisomerase‐II expression in patients with advanced non‐small cell lung cancer treated with amrubicin. Thoracic cancer. 11 (2), pp. 426-435. [Online]. 
  
Back to record